Benitez Fuentes J, Bartolome Arcilla J, Lazaro Sanchez A, de Luna Aguilar A, Mohamed Mohamed K, Guevara-Hoyer K
Front Oncol. 2025; 15:1525924.
PMID: 40066089
PMC: 11891020.
DOI: 10.3389/fonc.2025.1525924.
Wang M, Gu C, Yang Y, Chen L, Chen K, Du J
Front Neurol. 2023; 14:1269862.
PMID: 38107649
PMC: 10723162.
DOI: 10.3389/fneur.2023.1269862.
Manoharan Valerio M, Arana K, Guan J, Chan S, Yang X, Kurd N
Front Immunol. 2023; 14:1250316.
PMID: 38022509
PMC: 10644506.
DOI: 10.3389/fimmu.2023.1250316.
Kim H, Nakagawa H, Choi J, Che X, Divris A, Liu Q
J Clin Invest. 2023; 134(1).
PMID: 37934601
PMC: 10760956.
DOI: 10.1172/JCI170512.
Pishesha N, Harmand T, Ploegh H
Nat Rev Immunol. 2022; 22(12):751-764.
PMID: 35418563
DOI: 10.1038/s41577-022-00707-2.
A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening.
Vaurs J, Douchin G, Echasserieau K, Oger R, Jouand N, Fortun A
Sci Rep. 2021; 11(1):17234.
PMID: 34446788
PMC: 8390762.
DOI: 10.1038/s41598-021-96560-9.
Qa-1 Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing.
Zhang X, Sabio E, Krishna C, Ma X, Wang J, Jiang H
Mol Cancer Res. 2021; 19(6):1076-1084.
PMID: 33674442
PMC: 8178214.
DOI: 10.1158/1541-7786.MCR-20-0652.
Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.
Ruibal P, Franken K, van Meijgaarden K, van Loon J, van der Steen D, Heemskerk M
J Immunol. 2020; 205(10):2861-2872.
PMID: 33020145
PMC: 7653511.
DOI: 10.4049/jimmunol.2000810.
Dimorphism of HLA-E and its Disease Association.
Kanevskiy L, Erokhina S, Kobyzeva P, Streltsova M, Sapozhnikov A, Kovalenko E
Int J Mol Sci. 2019; 20(21).
PMID: 31690066
PMC: 6862560.
DOI: 10.3390/ijms20215496.
Monalizumab: inhibiting the novel immune checkpoint NKG2A.
van Hall T, Andre P, Horowitz A, Ruan D, Borst L, Zerbib R
J Immunother Cancer. 2019; 7(1):263.
PMID: 31623687
PMC: 6798508.
DOI: 10.1186/s40425-019-0761-3.
Senescent cells evade immune clearance via HLA-E-mediated NK and CD8 T cell inhibition.
Pereira B, Devine O, Vukmanovic-Stejic M, Chambers E, Subramanian P, Patel N
Nat Commun. 2019; 10(1):2387.
PMID: 31160572
PMC: 6547655.
DOI: 10.1038/s41467-019-10335-5.
HLA-E: exploiting pathogen-host interactions for vaccine development.
Sharpe H, Bowyer G, Brackenridge S, Lambe T
Clin Exp Immunol. 2019; 196(2):167-177.
PMID: 30968409
PMC: 6468186.
DOI: 10.1111/cei.13292.
HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residues.
Ho G, Heinen F, Huyton T, Blasczyk R, Bade-Doding C
Immunogenetics. 2019; 71(5-6):353-360.
PMID: 30941482
PMC: 6525141.
DOI: 10.1007/s00251-019-01112-1.
A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement.
Wang X, Piersma S, Nelson C, Dai Y, Christensen T, Lazear E
Elife. 2018; 7.
PMID: 30575523
PMC: 6320069.
DOI: 10.7554/eLife.38667.
Non-classical human leucocyte antigens in ankylosing spondylitis: possible association with HLA-E and HLA-F.
Santos M, Couto A, Foroni I, Bettencourt B, Li Z, Meneses R
RMD Open. 2018; 4(1):e000677.
PMID: 30018800
PMC: 6045739.
DOI: 10.1136/rmdopen-2018-000677.
HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
Jouand N, Bressollette-Bodin C, Gerard N, Giral M, Guerif P, Rodallec A
PLoS Pathog. 2018; 14(4):e1007041.
PMID: 29709038
PMC: 5945056.
DOI: 10.1371/journal.ppat.1007041.
T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1 with TAP-Independent Peptides Are Semi-Invariant Lymphocytes.
Doorduijn E, Sluijter M, Querido B, Seidel U, Oliveira C, van der Burg S
Front Immunol. 2018; 9:60.
PMID: 29422902
PMC: 5788890.
DOI: 10.3389/fimmu.2018.00060.
Crystal structure of Qa-1a with bound Qa-1 determinant modifier peptide.
Ying G, Wang J, Kumar V, Zajonc D
PLoS One. 2017; 12(8):e0182296.
PMID: 28767728
PMC: 5540586.
DOI: 10.1371/journal.pone.0182296.
MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.
Bian Y, Shang S, Siddiqui S, Zhao J, Joosten S, Ottenhoff T
PLoS Pathog. 2017; 13(5):e1006384.
PMID: 28475642
PMC: 5435364.
DOI: 10.1371/journal.ppat.1006384.
Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases.
Joosten S, Sullivan L, Ottenhoff T
J Immunol Res. 2016; 2016:2695396.
PMID: 27699181
PMC: 5028793.
DOI: 10.1155/2016/2695396.
